Compass Diversified (NYSE: CODI) has announced the appointment of Stephen Keller as the company's Chief Financial Officer, effective August 31, 2024. He will be taking over from Ryan Faulkingham, who has served as the CFO since July 2013.
Stephen Keller brings over 25 years of executive finance experience across multiple industries, including automotive, healthcare, industrial, specialty materials, retail and apparel branding, and media. He most recently served as the Interim CFO and VP of Investor Relations at Envista Holdings Corporation (NYSE: NVST), a $2.6 billion company and one of the leading suppliers of dental solutions globally.
During his time at Envista, he also held the positions of VP of Strategy and Business Development, as well as VP and General Manager of Nobel Biocare's prosthetics business unit. Prior to Envista, Mr. Keller worked at Avery Dennison Corporation (NYSE: AVY), an $8 billion global materials science company, where he held various positions of increasing responsibility in finance, strategy, and general management.
Elias Sabo, CEO of Compass Diversified, expressed his delight in welcoming Stephen to the company, noting his extensive experience at numerous public companies in financial leadership and other senior executive positions. He highlighted Stephen's inspirational leadership style and proven track record of driving strong financial results and instilling financial and operational discipline.
Mr. Keller also expressed his excitement in joining the company, emphasizing the diverse mix of disruptive and innovative middle-market businesses at Compass Diversified, along with its permanent capital base and long-term, disciplined approach to value creation.
In his new role, Mr. Keller will lead CODI's finance organization, including accounting, planning, treasury, tax, reporting, and investor relations. His appointment comes as Compass Diversified continues to execute its strategy of owning and managing a diverse set of highly defensible, middle-market businesses across the industrial, branded consumer, and healthcare sectors since its IPO in 2006. The company leverages its permanent capital base and long-term disciplined approach to maintain controlling ownership interests in each of its subsidiaries. Following these announcements, the company's shares moved -0.2%, and are now trading at a price of $22.08. If you want to know more, read the company's complete 8-K report here.
